These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10850299)

  • 1. Pretargeted peptide imaging and therapy.
    Goodwin DA; Meares CF
    Cancer Biother Radiopharm; 1999 Jun; 14(3):145-52. PubMed ID: 10850299
    [No Abstract]   [Full Text] [Related]  

  • 2. Attenuation correction in dosimetry.
    De Geeter F
    J Nucl Med; 2000 Sep; 41(9):1596. PubMed ID: 10994745
    [No Abstract]   [Full Text] [Related]  

  • 3. Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels-Alder Reaction and Key Factors in the Pretargeted Synthetic Design.
    Qiu L; Mao W; Yin H; Tan H; Cheng D; Shi H
    Contrast Media Mol Imaging; 2019; 2019():9182476. PubMed ID: 31531006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies and peptides in nuclear medicine imaging and therapy. Letter from the editors.
    Freeman LM; Blaufox MD
    Semin Nucl Med; 2010 May; 40(3):165-6. PubMed ID: 20350625
    [No Abstract]   [Full Text] [Related]  

  • 5. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
    Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
    J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preparation of radiolabeled monoclonal antibodies for human use.
    Tran L; Beijnen JH; Huitema AD
    Hum Antibodies; 2009; 18(4):145-56. PubMed ID: 19996529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunotherapy of MCF7 breast cancer cell line with 131I-PR81 monoclonal antibody against MUC1: comparison of direct and indirect radioiodination methods.
    Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Hasan ZM; Salouti M; Gandomkar M; Sadri K
    Hum Antibodies; 2010; 19(1):15-25. PubMed ID: 20555127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic model for radioimmunotherapy delivered through cerebrospinal fluid for the treatment of leptomeningeal metastases.
    Lv Y; Cheung NK; Fu BM
    J Nucl Med; 2009 Aug; 50(8):1324-31. PubMed ID: 19617331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 10th International Conference on Monoclonal Antibody Immunoconjugates for Cancer: Radiodosimetry and Radiopharmaceuticals for Therapy.
    Breitz H; Mills G; Siegel J; Stabin M; Wessels BW
    Cancer Biother Radiopharm; 1996 Feb; 11(1):25-42. PubMed ID: 10851518
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioimmunodetection and radioimmunotherapy of breast cancer.
    Riva P; Franceschi G; Gentile R; Riva N; Casi M
    Tumori; 1997; 83(2):552-7. PubMed ID: 9226019
    [No Abstract]   [Full Text] [Related]  

  • 11. A new radiopharmaceutical compound (131I-PR81) for radioimmunotherapy of breast cancer: labeling of antibody and its quality control.
    Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Zahir MH; Salouti M; Rajabi AB; Mazidi M
    Hum Antibodies; 2010; 19(4):79-88. PubMed ID: 21178279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.
    Kelly MP; Lee FT; Smyth FE; Brechbiel MW; Scott AM
    J Nucl Med; 2006 Apr; 47(4):716-25. PubMed ID: 16595507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncation of blood curves to enhance imaging and therapy with monoclonal antibodies.
    Williams LE; Liu A; Wu AM; Yazaki PJ; Yamauchi DM; Lopatin G; Raubitschek AA; Wong JY
    Med Phys; 2000 May; 27(5):988-94. PubMed ID: 10841401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution and scintigraphic studies of 153Sm-labeled anti-CEA monoclonal antibody for radioimmunoscintigraphy and radioimmunotherapy.
    Fani M; Xanthopoulos S; Archimandritis SC; Stratis N; Bouziotis P; Loudos G; Varvarigou AD
    Anticancer Res; 2003; 23(3A):2195-9. PubMed ID: 12894597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined modality radioimmunotherapy with Taxol and 90Y-Lym-1 for Raji lymphoma xenografts.
    O'Donnell RT; DeNardo SJ; Miers LA; Kukis DL; Mirick GR; Kroger LA; DeNardo GL
    Cancer Biother Radiopharm; 1998 Oct; 13(5):351-61. PubMed ID: 10851425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG; Oosterwijk E; Molkenboer-Kuenen JD; Soede AC; McBride BJ; Goldenberg DM; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2005 Mar; 46(3):495-501. PubMed ID: 15750164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
    Goodwin DA; Meares CF; Osen M
    J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor pretargeting: almost the bottom line.
    Goodwin DA
    J Nucl Med; 1995 May; 36(5):876-9. PubMed ID: 7738666
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.
    Boswell CA; Brechbiel MW
    Nucl Med Biol; 2007 Oct; 34(7):757-78. PubMed ID: 17921028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies in the diagnosis and treatment of the colorectal cancer.
    Dziki A
    Acta Chir Iugosl; 1998; 45(2 Suppl):35-6. PubMed ID: 10951784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.